Some Counterclaims Dropped From Coreg Patent Suit

Law360, New York (August 8, 2008, 12:00 AM EDT) -- Teva Pharmaceutical Industries Ltd. scored a win Thursday when a judge dropped a handful of counterclaims, including one alleging antitrust violations, from its patent infringement suit against Canadian generics maker Apotex Inc. over its patents for the congestive heart treatment Coreg.

Judge Garrett E. Brown, Jr. of the U.S. District Court for the District of New Jersey granted a majority of Teva’s motion to dismiss four counterclaims asserted by Apotex, leaving only unfair competition and tortious interference counterclaims relating to one of the four patents-in-suit....
To view the full article, register now.